XV. Multiple Myeloma and Cell Therapy Workshop
For the first time, due to the COVID pandemic, XV. Multiple Myeloma and III Cell Therapy Workshop will be held in a fully online version, and you are all invited!
We are happy to announce the XV. Multiple Myeloma & III. Cell therapy workshop on 12.11.2020 and we would like to invite you to follow the workshop, on 12 November 2020 from 9:30 AM CET at the following YouTube link: https://youtu.be/8WyM-UD0e4g
Unfortunately, due to the COVID pandemic situation, the regular Multiple Myeloma & Cell Therapy Workshop, which always takes place in the autumn, this year will be held in a fully online version.
During the session, you can ask questions via the sli.do page, by entering the event code: myeloma
However, you can join the workshop at any moment, and the workshop will be available even after the event for future viewers.
The program this year will have four major sections:
-
Genomics of monoclonal gammopathies
-
Novel molecular aspects in MM biology and therapy
-
In vivo models and CD38 in MM
-
Cell-based therapy section
-
Here all the details of the conference:
The program :
9:30 – 9:40
R.Hájek / M.Šimíček
Introduction
Genomics of monoclonal gammopathies
9:45 – 10:00
M.Zátopková
Genomics of minimal residual disease in MM
10:05 – 10:25
D.Žihala
Genomics in MM extramedullary disease
10:30 - 11:00 Break
Novel molecular aspects in MM biology and therapy
11:00 – 11:20
A.Vdovin
Proteasome inhibitor resistence in MM: a lesson from imunoglobulin synthesis
11:25 – 11:35
R.Šnaurová
Novel factors regulating Ig production in plasma cells
11:40 – 11:55
M.Turi
Analysis of MyD88 signalosome driving human lymphomas
12:00 - 13:00 Break
In vivo models and CD38 in MM
13:00 – 13:15
M.Hrdinka
Mouse models in hematooncology
13:20 – 13:35
H.Šahinbegović
Many aspects of CD38 targetability in MM
13:40 – 13:55
T.Jelínek
Daratumumab in MM extramedullary disease
14:00 - 14:30 Break
Cell-based therapy section
14:30 – 14:45
P. Celichowski
Immunotherapy with universal T cells
14:50 – 15:05
B.Motais
Allogeneic NK cells for cancer treatment
15:10 – 15:25
I.Demel
NK cell therapy - results of clinical trials
15:30 – 15:45
T.Ševčíková
Follow-up ALA genomics project - review and project design
15:50-16:05
B.Wingham (IsoPlexis)
Functional Immune Phenotyping
16:10 – 16:30
Open discussion
16:35 – 16:40
R.Hájek / M.Šimíček
Concluding remarks
We are looking forward to a virtual meeting with you!
Professional guarantor of the program:
RNDr. Michal Simicek, PhD.
Seminar secretariat:
HANZO PRODUCTION, SPOL. s ro
Jan Lapes
mobile: +420 734 338 328
email: lapes@hanzo.cz
Workshop partners
![]() |
![]() |
![]() |
Projekt OP VVV Nové směry biomedicínského výzkumu na Ostravsku, reg.č. CZ.02.1.01/0.0/0.0/18_069/0010060 byl podporován z Evropských strukturálních a investičních fondů
12.10.2020